ArticleFrontiers in public health2026
Lifetime cost-effectiveness of lecanemab for early Alzheimer's disease.
Xiangxiang Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleFrontiers in public health2026
Xiangxiang Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.